These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16721698)

  • 1. Catecholamine response to methamphetamine is related to glucocorticoid levels but not to pleasurable subjective response.
    Harris DS; Reus VI; Wolkowitz O; Jacob P; Everhart ET; Wilson M; Mendelson JE; Jones RT
    Pharmacopsychiatry; 2006 May; 39(3):100-8. PubMed ID: 16721698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altering cortisol level does not change the pleasurable effects of methamphetamine in humans.
    Harris DS; Reus VI; Wolkowitz OM; Mendelson JE; Jones RT
    Neuropsychopharmacology; 2003 Sep; 28(9):1677-84. PubMed ID: 12813474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone increases plasma HVA but not MHPG in normal humans.
    Wolkowitz OM; Sutton ME; Doran AR; Labarca R; Roy A; Thomas JW; Pickar D; Paul SM
    Psychiatry Res; 1985 Oct; 16(2):101-9. PubMed ID: 3865250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-pituitary-adrenal axis effects on plasma homovanillic acid in man.
    Posener JA; Schatzberg AF; Williams GH; Samson JA; McHale NL; Bessette MP; Schildkraut JJ
    Biol Psychiatry; 1999 Jan; 45(2):222-8. PubMed ID: 9951570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished cortisol levels in subordinate female marmosets are associated with altered central drive to the hypothalamic-pituitary-adrenal axis.
    Saltzman W; Hogan BK; Abbott DH
    Biol Psychiatry; 2006 Oct; 60(8):843-9. PubMed ID: 16499881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.
    Wolkowitz OM; Doran AR; Breier A; Roy A; Jimerson DC; Sutton ME; Golden RN; Paul SM; Pickar D
    Arch Gen Psychiatry; 1987 Sep; 44(9):782-9. PubMed ID: 3632251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
    Raedler TJ; Jahn H; Goedeken B; Gescher DM; Kellner M; Wiedemann K
    Depress Anxiety; 2006; 23(3):139-44. PubMed ID: 16470820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids.
    Wolkowitz OM
    Psychoneuroendocrinology; 1994; 19(3):233-55. PubMed ID: 7515507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the cortisol synthesis inhibitor metyrapone on the response to carbon dioxide challenge in panic disorder.
    Belgorodsky A; Knyazhansky L; Loewenthal U; Arbelle J; Cohen H; Benjamin J
    Depress Anxiety; 2005; 21(3):143-8. PubMed ID: 16001448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects of megestrol on the hypothalamic-pituitary-adrenal axis.
    Raedler TJ; Jahn H; Goedeken B; Gescher DM; Kellner M; Wiedemann K
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):482-6. PubMed ID: 13680163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unconjugated methoxylated catecholamine metabolites in human saliva. Quantitation methodology and comparison with plasma levels.
    Drebing CJ; Freedman R; Waldo M; Gerhardt GA
    Biomed Chromatogr; 1989 Sep; 3(5):217-20. PubMed ID: 2804429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep endocrine effects of the 11-beta-hydroxysteroiddehydrogenase inhibitor metyrapone.
    Jahn H; Kiefer F; Schick M; Yassouridis A; Steiger A; Kellner M; Wiedemann K
    Sleep; 2003 Nov; 26(7):823-9. PubMed ID: 14655915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary response to metyrapone in Gulf War veterans: relationship to deployment, PTSD and unexplained health symptoms.
    Golier JA; Schmeidler J; Yehuda R
    Psychoneuroendocrinology; 2009 Oct; 34(9):1338-45. PubMed ID: 19446401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid receptor function in posttraumatic stress disorder after pretreatment with metyrapone.
    Otte C; Muhtz C; Daneshkhah S; Yassouridis A; Kiefer F; Wiedemann K; Kellner M
    Biol Psychiatry; 2006 Oct; 60(7):784-7. PubMed ID: 16566900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metyrapone and cocaine: a double-blind, placebo-controlled drug interaction study.
    Winhusen T; Somoza E; Harrer JM; Moore E; Ussery T; Kropp F; Singal B; Elkashef A; Mojsiak J
    Pharmacol Biochem Behav; 2005 Apr; 80(4):631-8. PubMed ID: 15820533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of the corticosteroid-dopaminergic interaction during metyrapone and dexamethasone administration.
    Lupien S; Richter R; Risch SC; Mirow A; Gillin JC; Hauger RL
    Psychiatry Res; 1995 Sep; 58(1):23-35. PubMed ID: 8539309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of intravenous heroin on the hypothalamic-pituitary-adrenal axis response: a controlled trial.
    Walter M; Gerber H; Kuhl HC; Schmid O; Joechle W; Lanz C; Brenneisen R; Schächinger H; Riecher-Rössler A; Wiesbeck GA; Borgwardt SJ
    J Clin Psychopharmacol; 2013 Apr; 33(2):193-8. PubMed ID: 23422375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in saliva and plasma of healthy volunteers.
    Yang RK; Yehuda R; Holland DD; Knott PJ
    Biol Psychiatry; 1997 Nov; 42(9):821-6. PubMed ID: 9347131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine.
    Stine SM; Grillon CG; Morgan CA; Kosten TR; Charney DS; Krystal JH
    Psychopharmacology (Berl); 2001 Mar; 154(3):274-81. PubMed ID: 11351934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder.
    Mitropoulou V; Goodman M; Sevy S; Elman I; New AS; Iskander EG; Silverman JM; Breier A; Siever LJ
    Schizophr Res; 2004 Sep; 70(1):27-31. PubMed ID: 15246460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.